VeriSee DR is a diagnostic software for diabetic retinopathy (DR), developed by AcerMedical. It uses AI and assists healthcare professionals to analyse retinal images for signs of DR and immediately outputs recommendations on whether the patient should be referred to ophthalmologists.
With 93% screening accuracy that is comparable to ophthalmologists, and approvals by Taiwan, Thailand, Indonesia and the Philippines' FDAs, VeriSee DR is an effective solution that can:
- Shorten the screening process
- Increase the volume of screenings
- Improve the accuracy and consistency of the results
- Reduce costs
- Improve patient outcomes
